CAM
TMO icon

Cresset Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Cresset Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-300
Closed -$156K – 1854
2024
Q4 		$156K Sell
300
-400
-57% -$220K ﹤0.01% 1594
2024
Q3 		$433K Sell
700
-2,300
-77% -$1.36M ﹤0.01% 1611
2024
Q2 		$1.66M Buy
+3,000
New +$1.72M 0.01% 813

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cresset Asset Management's TMO Position: Q1 2026 in Review

Cresset Asset Management increased its Thermo Fisher Scientific (TMO) stake by 3.6% in Q1 2026, buying an estimated $823K and bringing the position to 43,748 shares worth $21.5M. The position accounts for 0.09% of the portfolio, ranked #147.

Cresset Asset Management first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $36.3M in Q3 2024. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Cresset Asset Management held 43,748 shares of Thermo Fisher Scientific worth $21.5M as of Q1 2026.
  • Cresset Asset Management bought 1,516 Thermo Fisher Scientific shares in Q1 2026, an estimated $823K.
  • Thermo Fisher Scientific made up 0.09% of Cresset Asset Management's portfolio in Q1 2026, its #147 holding.
  • Cresset Asset Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Thermo Fisher Scientific position peaked at $36.3M in Q3 2024.
  • 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.